Falling Behind

Research on human embryonic stem cells should absolutely get federal funding, writes David Scadden in a column for the Boston Globe. The co-director of the Harvard Stem Cell Institute says that the US is losing out when it comes to stem cells, as funding controversies are forcing some researchers to halt their work and others to leave the country to work overseas.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor among brittle stars, single-cell RNA sequencing strategy, and more.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.